Menu
Currency
GWAS Study

HLA-DPB1 is associated with ANCA-associated vasculitis in children.

Gibson KM, Drögemöller BI, Foell D et al.

36530128 PubMed ID
GWAS Study Type
378 Participants
49 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GK
Gibson KM
DB
Drögemöller BI
FD
Foell D
BS
Benseler SM
GJ
Graham J
HR
Hancock REW
LR
Luqmani RA
CD
Cabral DA
BK
Brown KL
RC
Ross CJ
Chapter II

Abstract

Summary of the research findings

Objective: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare, life-threatening inflammation of blood vessels that can affect both adults and children. Compared to adult-onset disease, AAV is especially rare in children, with an annual prevalence of 0.5-6.4 cases per million children. The etiology of AAV remains largely unknown, and both environmental and genetic factors are likely involved. The present study was undertaken to explore the genetic susceptibility factors recently identified in adult patients, including HLA-DP and HLA-DQ, in pediatric patients.

63 European ancestry pediatric cases, 315 European ancestry pediatric controls

Chapter III

Study Statistics

Key metrics and study information

378
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.